First line versus second line use of reslizumab in severe uncontrolled asthma. Perez de Llano LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, et al. J Investig Allergol Clin Immunol 2022 Jun 27:0. doi: 10.18176/jiaci.0839.

Read + Share

Amedeo Smart

Independent Medical Education

Perez de Llano LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, et al. First line versus second line use of reslizumab in severe uncontrolled asthma. J Investig Allergol Clin Immunol 2022 Jun 27:0. doi: 10.18176/jiaci.0839.
PMID: 35797112